News Daily News Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol Michael O'Riordan August 06, 2025
News Daily News AF Patients Could Benefit From Exercise-Based Cardiac Rehab Caitlin E. Cox August 05, 2025
News Daily News AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty Caitlin E. Cox June 13, 2025
News Conference News European Congress on Obesity 2025 Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity Michael O'Riordan May 16, 2025
News Conference News European Congress on Obesity 2025 Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery Michael O'Riordan May 14, 2025
News Conference News EAS 2025 Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM Yael L. Maxwell May 08, 2025
News Daily News Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention Michael O'Riordan May 07, 2025
News Conference News CX Symposium 2025 Plant-Derived Compound Shows Early Promise for Small AAAs L.A. McKeown April 25, 2025
News Daily News Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy Caitlin E. Cox April 14, 2025
News Conference News ACC 2025 ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a) L.A. McKeown April 10, 2025
News Daily News Newer Weight-Loss Drugs Not Cost-effective at Current Prices Michael O'Riordan March 18, 2025
News Daily News CV Screening, Care at UK Football Club Made Inroads Against HF Caitlin E. Cox March 07, 2025
News Daily News Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit Yael L. Maxwell February 12, 2025
News Daily News Global Commission Proposes ‘Radical’ Overhaul of Obesity Diagnosis L.A. McKeown January 14, 2025